These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24228186)

  • 21. Tracking mitochondrial Cu(I) fluctuations through a ratiometric fluorescent probe in AD model cells: Towards understanding how AβOs induce mitochondrial Cu(I) dyshomeostasis.
    Zhao Q; Ma L; Chen S; Huang L; She G; Sun Y; Shi W; Mu L
    Talanta; 2024 May; 271():125716. PubMed ID: 38301373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-Ceruloplasmin Copper Distinguishes A Distinct Subtype of Alzheimer's Disease: A Study of EEG-Derived Brain Activity.
    Tecchio F; Vecchio F; Ventriglia M; Porcaro C; Miraglia F; Siotto M; Rossini PM; Rongioletti M; Squitti R
    Curr Alzheimer Res; 2016; 13(12):1374-1384. PubMed ID: 27335037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of brain-derived extracellular vesicle lipids in Alzheimer's disease.
    Su H; Rustam YH; Masters CL; Makalic E; McLean CA; Hill AF; Barnham KJ; Reid GE; Vella LJ
    J Extracell Vesicles; 2021 May; 10(7):e12089. PubMed ID: 34012516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mineral status and superoxide dismutase enzyme activity in Alzheimer's disease.
    Rodrigues GP; Cozzolino SMF; Marreiro DDN; Caldas DRC; da Silva KG; de Sousa Almondes KG; Neto JMM; Pimentel JAC; de Carvalho CMRG; Nogueira NDN
    J Trace Elem Med Biol; 2017 Dec; 44():83-87. PubMed ID: 28965606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Cerebral Metal Ion Imbalance in the Brain of Aging
    Braidy N; Poljak A; Marjo C; Rutlidge H; Rich A; Jugder BE; Jayasena T; Inestrosa NC; Sachdev PS
    Front Aging Neurosci; 2017; 9():66. PubMed ID: 28405187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
    Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
    J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metal dyshomeostasis and oxidative stress in Alzheimer's disease.
    Greenough MA; Camakaris J; Bush AI
    Neurochem Int; 2013 Apr; 62(5):540-55. PubMed ID: 22982299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redox active metals in neurodegenerative diseases.
    Acevedo K; Masaldan S; Opazo CM; Bush AI
    J Biol Inorg Chem; 2019 Dec; 24(8):1141-1157. PubMed ID: 31650248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copper phenotype in Alzheimer's disease: dissecting the pathway.
    Squitti R; Polimanti R
    Am J Neurodegener Dis; 2013; 2(2):46-56. PubMed ID: 23844331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imbalances in Copper or Zinc Concentrations Trigger Further Trace Metal Dyshomeostasis in Amyloid-Beta Producing
    Metaxas A
    Front Neurosci; 2021; 15():755475. PubMed ID: 34707479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic redistribution of metal ions to treat Alzheimer's disease.
    Crouch PJ; Barnham KJ
    Acc Chem Res; 2012 Sep; 45(9):1604-11. PubMed ID: 22747493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.
    Vaikath NN; Erskine D; Morris CM; Majbour NK; Vekrellis K; Li JY; El-Agnaf OMA
    Neuropathol Appl Neurobiol; 2019 Oct; 45(6):597-608. PubMed ID: 30422353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic copper exposure directs microglia towards degenerative expression signatures in wild-type and J20 mouse model of Alzheimer's disease.
    Lim SL; Rodriguez-Ortiz CJ; Hsu HW; Wu J; Zumkehr J; Kilian J; Vidal J; Ayata P; Kitazawa M
    J Trace Elem Med Biol; 2020 Dec; 62():126578. PubMed ID: 32599538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cu
    Du C; Feng W; Dai X; Wang J; Geng D; Li X; Chen Y; Zhang J
    Small; 2022 Sep; 18(39):e2203031. PubMed ID: 36008124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls.
    Szabo ST; Harry GJ; Hayden KM; Szabo DT; Birnbaum L
    Toxicol Sci; 2016 Apr; 150(2):292-300. PubMed ID: 26721301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selenium homeostasis in human brain cells: Effects of copper (II) and Se species.
    Raschke S; Ebert F; Kipp AP; Kopp JF; Schwerdtle T
    J Trace Elem Med Biol; 2023 Jul; 78():127149. PubMed ID: 36948045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metals, oxidative stress and neurodegenerative disorders.
    Jomova K; Vondrakova D; Lawson M; Valko M
    Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Copper modulation as a therapy for Alzheimer's disease?
    Manso Y; Comes G; Hidalgo J; Bush AI; Adlard PA
    Int J Alzheimers Dis; 2011; 2011():370345. PubMed ID: 21876828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain ureido degenerative protein modifications are associated with neuroinflammation and proteinopathy in Alzheimer's disease with cerebrovascular disease.
    Gallart-Palau X; Serra A; Lee BST; Guo X; Sze SK
    J Neuroinflammation; 2017 Sep; 14(1):175. PubMed ID: 28865468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copper in Alzheimer's disease: a meta-analysis of serum,plasma, and cerebrospinal fluid studies.
    Bucossi S; Ventriglia M; Panetta V; Salustri C; Pasqualetti P; Mariani S; Siotto M; Rossini PM; Squitti R
    J Alzheimers Dis; 2011; 24(1):175-85. PubMed ID: 21187586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.